A Creutzfeldt–Jakob disease patient with V180I mutation survived for 16.5 years after diagnosis

Author(s):  
Nayoung Ryoo ◽  
SangHak Yi ◽  
Seong Soo A. An ◽  
Young Ho Park ◽  
SangYun Kim
2013 ◽  
Vol 53 (3) ◽  
pp. 235-238 ◽  
Author(s):  
Hiroshi Shimizu ◽  
Yusei Shiga ◽  
Arifumi Matsumoto ◽  
Kinya Hisanaga

BMC Neurology ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Hee Jin Kim ◽  
Hanna Cho ◽  
Seongbeom Park ◽  
Hyemin Jang ◽  
Young Hoon Ryu ◽  
...  

Neurology ◽  
1992 ◽  
Vol 42 (6) ◽  
pp. 1249-1249 ◽  
Author(s):  
J. Chapman ◽  
P. Brown ◽  
J. M. Rabey ◽  
L. G. Goldfarb ◽  
R. Inzelberg ◽  
...  

Neurology ◽  
1993 ◽  
Vol 43 (2) ◽  
pp. 447-447 ◽  
Author(s):  
P. Labauge ◽  
M. Pages ◽  
J.-M. Blard ◽  
J. Chatelain ◽  
J.-L. Laplanche

Prion ◽  
2011 ◽  
Vol 5 (3) ◽  
pp. 232-234 ◽  
Author(s):  
Cao Chen ◽  
Qi Shi ◽  
Chan Tian ◽  
Qing Li ◽  
Wei Zhou ◽  
...  

Viruses ◽  
2021 ◽  
Vol 13 (10) ◽  
pp. 2061
Author(s):  
Aušrinė Areškevičiūtė ◽  
Eva Løbner Lund ◽  
Sabina Capellari ◽  
Piero Parchi ◽  
Christian Tersbøl Pinkowsky

In the present manuscript, we report the clinical presentation and challenging diagnostic work-up of a sporadic Creutzfeldt–Jakob disease patient with confirmed VV1 subtype and heterozygous 1-octapeptide repeat deletion in the prion protein gene. The described patient was a 58-year-old woman. Interestingly, most of the reported patients with the VV1 subtype to date are men with an average age of 44 years at disease onset. The patient was observed clinically from symptoms onset until her death 22 months later. This report describes the patient’s insidious clinical evolution and the paraclinical examinations and pathology reports gathered at different time points of disease progression. Unfortunately, the absence of typical clinical and paraclinical features of classic sporadic Creutzfeldt–Jakob disease made the brain biopsy surgery necessary. This case report illustrates the diagnostic difficulties posed by the phenotypic heterogeneity of sporadic Creutzfeldt–Jakob disease and urges clinicians to consider this diagnosis even in patients who do not fulfil the typical clinical disease criteria. Furthermore, it highlights the need for real-time quaking-induced conversion method adaptation for detection of rare sporadic Creutzfeldt–Jakob disease subtypes with certain prion protein gene variants.


Prion ◽  
2011 ◽  
Vol 5 (2) ◽  
pp. 117-120 ◽  
Author(s):  
Qi Shi ◽  
Cao Chen ◽  
Xiao-Nan Song ◽  
Chen Gao ◽  
Chan Tian ◽  
...  

2020 ◽  
Vol 79 (4) ◽  
pp. 419-429
Author(s):  
Shoko Sadashima ◽  
Hiroyuki Honda ◽  
Satoshi O Suzuki ◽  
Masahiro Shijo ◽  
Shinichi Aishima ◽  
...  

Abstract Gerstmann-Sträussler-Scheinker (GSS) disease with P102L mutation and familial Creutzfeldt-Jakob disease (CJD) with V180I mutation are 2 major hereditary prion diseases in Japan. GSS and some familial CJD [V180I] exhibit characteristic prion protein (PrP) plaques. Overexpression of the astrocytic water channel proteins aquaporin (AQP) 1 and AQP4 was recently reported in sporadic CJD. To clarify the pathological characteristics of AQP1 and AQP4 in prion disease patient brains with plaque-type deposition, we investigated 5 patients with GSS, 2 patients with CJD [V180I], and 2 age-matched control cases without neurological diseases using immunohistochemistry and double immunofluorescence methods. We demonstrated that there is the intense expression of AQP1 and AQP4 around prion plaques, especially in distal astrocytic processes deep inside these plaques. Similar results have been reported in the senile plaques and ghost tangles of Alzheimer disease brains and a protective role of AQP4 in which AQP4 is redistributed toward the plaques and works as a barrier against the deleterious effects of these plaques has been suggested. Our results, which show a similar clustering of AQPs around PrP plaques, therefore support the possibility that AQPs also have a protective role in plaque formation in prion diseases.


Sign in / Sign up

Export Citation Format

Share Document